Dossier
PDE5 inhibitor
Coverage of PDE5 inhibitor in the Nexus archive.
- Use of PDE5 Inhibitor Tied to Increased Glaucoma Risk
A large retrospective study found that men using the PDE5 inhibitor tadalafil (Cialis) for lower urinary tract symptoms had an increased likelihood of developing glaucoma-related clinical events. The association between tadalafil use and glaucoma risk was highlighted as a key finding.